Medline Inc.
MDLN
$41.46
$0.390.95%
NASDAQ
| 12/31/2025 | 09/27/2025 | 06/28/2025 | 03/28/2025 | ||
|---|---|---|---|---|---|
| Revenue | 14.78% | 11.38% | 11.33% | 9.69% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 14.78% | 11.38% | 11.33% | 9.69% | |
| Cost of Revenue | 19.06% | 13.15% | 10.13% | 9.30% | |
| Gross Profit | 3.40% | 6.72% | 14.62% | 10.72% | |
| SG&A Expenses | 8.68% | 12.96% | 11.27% | 11.76% | |
| Depreciation & Amortization | -0.56% | 2.31% | 4.76% | 4.78% | |
| Other Operating Expenses | 87.50% | -63.64% | 600.00% | 1,100.00% | |
| Total Operating Expenses | 16.76% | 12.50% | 10.37% | 9.89% | |
| Operating Income | -10.32% | 0.00% | 21.90% | 7.59% | |
| Income Before Tax | -32.46% | 2.07% | 19.67% | 15.59% | |
| Income Tax Expenses | 62.50% | 64.29% | 225.00% | 162.50% | |
| Earnings from Continuing Operations | -37.72% | -0.62% | 14.04% | 11.58% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -37.02% | -0.62% | 14.04% | 11.58% | |
| EBIT | -10.32% | 0.00% | 21.90% | 7.59% | |
| EBITDA | -5.76% | 0.61% | 16.38% | 6.62% | |
| EPS Basic | 1,258.18% | -- | -- | -- | |
| Normalized Basic EPS | 1,853.64% | -- | -- | -- | |
| EPS Diluted | 1,258.18% | -- | -- | -- | |
| Normalized Diluted EPS | 1,853.64% | -- | -- | -- | |
| Average Basic Shares Outstanding | -95.35% | -- | -- | -- | |
| Average Diluted Shares Outstanding | -95.35% | -- | -- | -- | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -0.89% | 1.85% | 1.27% | 1.32% | |